Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Additional information
Address reprint requests to: Jose Antonio Apud, Fidia-Georgetown Institute for the Neurosciences, Georgetown University Medical School, 3900 Reservoir Road NW, Washington, D.C. 20007.
Rights and permissions
About this article
Cite this article
Apud, J. The 5-HT3 Receptor in Mammalian Brain: A New Target for the Development of Psychotropic Drugs?. Neuropsychopharmacol 8, 117–130 (1993). https://doi.org/10.1038/npp.1993.13
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/npp.1993.13
Keywords
This article is cited by
-
Modulation of Ligand-gated Ion Channels by Antidepressants and Antipsychotics
Molecular Neurobiology (2007)
-
Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner
Molecular Psychiatry (2004)
-
Serotonin 5-HT3 receptor binding kinetics in the cortex of suicide victims are normal
Journal of Neural Transmission (1996)
-
ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity
Psychopharmacology (1995)
